Latest Updates

PhoenixMD's lead program, PMD-026, is the first RSK inhibitor built for the treatment of triple-negative breast cancer (TNBC)

The fair trade regulator held the drug companies responsible for mandating the requirement of obtaining NOC (No Objection…

The drug, Calquence, showed meaningful improvement in patients with lymphocytic leukaemia when compared with a chemotherapy-based…

The company said it will provide due justifications and corrective action plan within next 15 working days to address the US FDA…

In the aesthetics market in India, BOTOX is currently licensed for the temporary improvement in moderate-to-severe glabellar lines…

The approved drug is therapeutically equivalent to the reference listed drug Sinemet CR tablets of Merck Sharp and Dohme

Emgality, the drug, belongs to a new class of drugs called CGRP inhibitors that are used to prevent migraines or reduce their…

Both Praluent, manufactured by Sanofi, and Repatha by Amgen, belong to a class of PCSK9 inhibitors, used against persistently…

Attending the largest biotechnology expo in USA, Philadelphia, the Karnataka government's delegation will also include six…

The overall program aimed at understanding and delving deeper into what is coming in the space of automation and utilization of…